Trustmark National Bank Trust Department’s Biogen BIIB Stock Holding History

Trustmark National Bank Trust Department’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-185	Closed	-$43K	–	265
2019 Q2	$43K	Sell	185 -5,988	-97%	-$1.38M	﹤0.01%	365
2019 Q1	$1.46M	Sell	6,173 -35	-0.6%	-$11K	0.15%	99
2018 Q4	$1.87M	Buy	6,208 +13	+0.2%	+$4.15K	0.21%	83
2018 Q3	$2.19M	Sell	6,195 -75	-1%	-$25.8K	0.22%	85
2018 Q2	$1.82M	Buy	6,270 +20	+0.3%	+$5.62K	0.21%	95
2018 Q1	$1.71M	Buy	+6,250	New	+$1.94M	0.18%	96
2016 Q2	–	Sell	-1,120	Closed	-$292K	–	296
2016 Q1	$292K	Sell	1,120 -50	-4%	-$13.2K	0.04%	243
2015 Q4	$358K	Sell	1,170 -20	-2%	-$5.75K	0.05%	226
2015 Q3	$347K	Sell	1,190 -2,885	-71%	-$953K	0.05%	239
2015 Q2	$1.65M	Sell	4,075 -110	-3%	-$44.1K	0.22%	98
2015 Q1	$1.77M	Buy	4,185 +760	+22%	+$300K	0.23%	93
2014 Q4	$1.16M	Buy	3,425 +15	+0.4%	+$4.85K	0.16%	134
2014 Q3	$1.13M	Sell	3,410 -160	-4%	-$52.8K	0.16%	135
2014 Q2	$1.13M	Sell	3,570 -600	-14%	-$181K	0.13%	142
2014 Q1	$1.27M	Sell	4,170 -980	-19%	-$311K	0.15%	124
2013 Q4	$1.44M	Sell	5,150 -2,100	-29%	-$543K	0.17%	113
2013 Q3	$1.75M	Sell	7,250 -30	-0.4%	-$6.71K	0.22%	89
2013 Q2	$1.57M	Buy	+7,280	New	+$1.56M	0.2%	98

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Trustmark National Bank Trust Department's BIIB Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of Biogen (BIIB) in Q3 2019, closing a stake of 185 shares — an estimated $43K sold.

Trustmark National Bank Trust Department first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $2.19M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 185 Biogen shares in Q3 2019, an estimated $43K.
Trustmark National Bank Trust Department first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
Trustmark National Bank Trust Department's Biogen position peaked at $2.19M in Q3 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.